Thomas Fuchs
托马斯·富克斯
PhD
Dean of Artificial Intelligence & Human Health, Weill Cornell; Co-founder & Chief Scientist, Paige.AI威尔康奈尔人工智能与人类健康学院院长；Paige.AI联合创始人兼首席科学家
👥Biography 个人简介
Thomas Fuchs is a pioneer in computational pathology and the founding Dean of AI at Weill Cornell Medicine. He co-founded Paige.AI, which developed the first FDA-cleared AI product for cancer diagnosis in digital pathology. His research on large-scale weakly supervised learning from pathology slides has transformed automated cancer detection and grading.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
First FDA-Cleared AI Cancer Pathology
Led development of Paige Prostate, the first FDA-cleared AI-powered digital pathology tool for prostate cancer diagnosis, marking a milestone for regulatory approval of computational pathology AI.
Large-Scale Weakly Supervised Pathology
Developed novel weakly supervised deep learning approaches trained on millions of MSKCC pathology slides, achieving pathologist-level cancer detection without pixel-level annotation.
Representative Works 代表性著作
Clinical-Grade Computational Pathology Using Weakly Supervised Consistency Training on Whole Slide Images
Nature Medicine (2021)
Demonstrated clinical-grade AI for prostate cancer detection using weakly supervised learning on 12,000+ slides.
Artificial Intelligence-Based Pathology for Gastrointestinal and Hepatobiliary Cancers
The Lancet Gastroenterology & Hepatology (2019)
Review of AI pathology advances for GI and hepatobiliary cancers and translation to clinical practice.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
关注 托马斯·富克斯 的研究动态
Follow Thomas Fuchs's research updates
留下邮箱，当我们发布与 Thomas Fuchs（Weill Cornell Medicine / Paige.AI）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment